Blog
RSS FeedPosted by Michael Wonder on 01 Feb 2023
Changes applying to evaluation of new substances for listed medicines
1 February 2023 - The TGA has introduced Mandatory requirements for applications to vary the Permissible Ingredients Determination under section 26BD ...
Posted by Michael Wonder on 28 Jun 2022
Fees and charges: summary from 1 July 2022
27 June 2022 - The TGA has updated its summary of fees and charges effective 1 July 2022. ...
Posted by Michael Wonder on 23 Jun 2021
Fees and charges: summary from 1 July 2021
23 June 2021 - The TGA is required to recover its costs for all activities that fall within the scope of ...
Posted by Michael Wonder on 03 Feb 2021
Cost recovery implementation statement (2020-2021)
3 February 2021 - This Cost Recovery Implementation Statement provides information on how the Therapeutic Goods Administration, within the Department of ...
Posted by Michael Wonder on 02 Jul 2020
Reduced annual charges for medical devices listed on the prostheses list
2 July 2020 - In response to the suspension of elective surgery due to COVID-19 and the significant impact this has ...
Posted by Michael Wonder on 23 Jun 2020
Submissions received: fees and charges proposal 2020-21
23 June 2020 - On 20 January 2020, the Therapeutic Goods Administration (TGA) released on its website a consultation paper, ...
Posted by Michael Wonder on 18 Jun 2020
Fees and charges: summary from 1 July 2020
18 June 2020 - The TGA is required to recover its costs for all activities that fall within the scope of ...
Posted by Michael Wonder on 20 Jan 2020
Fees and charges proposal 2020-21
20 January 2020 - The TGA is undertaking a consultation through its website to seek stakeholder's views on TGA’s proposed fees ...
Posted by Michael Wonder on 02 Jul 2019
Schedule of fees and charges
2 July 2019 - 2019-20 fees and charges schedule applies to applications submitted to the TGA on or after 1 July ...
Posted by Michael Wonder on 21 Jun 2019
Cost recovery implementation statement
21 June 2019 - The cost recovery implementation statement outlines the TGA's regulatory costs and provides detailed information on TGA's ...
Posted by Michael Wonder on 23 May 2019
TGA fees and charges: summary from 1 July 2019
23 May 2019 - The TGA is required to recover its costs for all activities that fall within the scope ...
Posted by Michael Wonder on 12 Oct 2018
TGA fees and charges: summary from 1 July 2018
12 October 2018 - The TGA is required to recover its costs for all activities that fall within the scope of ...
Posted by Michael Wonder on 04 Jul 2017
Cost recovery implementation statement 2017-18
4 July 2017 - This Cost Recovery Implementation Statement provides information on how the TGA implements cost recovery activities associated with ...
Posted by Michael Wonder on 18 Jul 2016
TGA cost recovery implementation statement 2016-17
18 July 2016 - This Cost Recovery Implementation Statement provides information on how the TGA implements cost recovery activities associated with ...
Posted by Michael Wonder on 01 Jul 2016
TGA fees and charges from 1 July 2016
1 July 2016 - The TGA has published a summary of fees and charges, which are in the Australian therapeutic goods ...